Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

Pharmaceuticals : Displaying 25-33 of 33


Deadly Blow to Death Penalty Drugs
by Pratap ChatterjeeCorpWatch Blog
March 28th, 2012
U.S. imports of sodium thiopental have been banned by a federal judge because of the poor quality of imports. The ruling has struck a serious blow against the death penalty because of the key role the drug plays in lethal injections. Not surprisingly, the state of Texas is furious.

India Ends Bayer Monopoly, Helps Slash Prices for Life-Saving Drugs
by Pratap ChatterjeeCorpWatch Blog
March 12th, 2012
The decision by PH Kurian, the controller general of patents, designs and trademarks in India, to allow a local company to manufacture Sorafenib, a drug used to treat advanced kidney cancer and liver cancer, is a welcome move that supports the access of poor people to cheap life-saving drugs.

Grey Market Drugs: Profiting from Poorly Managed U.S. Health Care
by Terry J. AllenSpecial to CorpWatch
January 22nd, 2012
Scalpers are doing a booming business in key medical drugs by taking advantage of U.S. patients and hospitals when they are desperate for supplies from the poorly regulated $46 billion global contract-manufacturing industry.

Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
by Shelley JofreSpecial to Corp Watch
July 30th, 2007
GlaxoSmithKline provides research funding to doctors who write favorable opinions of depression drugs for children, despite evidence from clinical trials that the medication can cause anger and even suicide.

Merck's Murky Dealings: HPV Vaccine Lobby Backfires
by Terry J. AllenSpecial to CorpWatch
March 7th, 2007
Merck's lobbying campaign for mandatory vaccination of school girls provided funding for a prominent women's non-profit. The ensuing uproar has created a backlash against the pharmaceutical giant.

Exporting Cures, Importing Misery
by By Stan CoxAlterNet
January 19th, 2005
The Kazipally industrial area once good farm country now accounts for more than one-third of India's pharmaceutical industry, meaning skyrocketing rates of cancer, heart disease and birth defects for its residents.

Biotechnology's Third Generation
by Carmelo Ruiz-MarreroSpecial to CorpWatch
April 5th, 2002
From golden rice to anti-viral tomatoes, is the biotech industry's third generation good medicine or good marketing? And, activists ask, what are the environmental consequences?

War Profiteering: Bayer, Anthrax and International Trade
by Kavaljit SinghAsia-Europe Dialogue Project
November 5th, 2001
US officials have refused to bust Bayer's monopoly on anthrax drugs, even though generic drugs would save $millions. Bayer's patent was protected under the WTO. Now those rights are challenged.

Silence = Death: AIDS, Africa and Pharmaceuticals
by Stephen LewisToronto Globe and Mail
January 26th, 2001
While 25 million Africans are living with AIDS, Northern pharmaceutical companies and governments are turning their back on the greatest tragedy of our time according to former deputy head of UNICEF.

Displaying 25-33 of 33  
< Prev  
« First Page 
« Show Complete List »